Show simple item record

dc.contributor.authorBeran, RG
dc.date.accessioned2017-05-03T14:19:57Z
dc.date.available2017-05-03T14:19:57Z
dc.date.issued2011
dc.date.modified2012-03-20T22:45:37Z
dc.identifier.issn1444-0903
dc.identifier.doi10.1111/j.1445-5994.2011.02575.x
dc.identifier.urihttp://hdl.handle.net/10072/43685
dc.description.publicationstatusYes
dc.languageEnglish
dc.language.isoeng
dc.publisherWiley-Blackwell Publishing Asia
dc.publisher.placeAustralia
dc.relation.ispartofstudentpublicationN
dc.relation.ispartofpagefrom757
dc.relation.ispartofpageto757
dc.relation.ispartofissue10
dc.relation.ispartofjournalInternal Medicine Journal
dc.relation.ispartofvolume41
dc.rights.retentionY
dc.subject.fieldofresearchCardiovascular medicine and haematology
dc.subject.fieldofresearchClinical sciences
dc.subject.fieldofresearchcode3201
dc.subject.fieldofresearchcode3202
dc.titleProlactinoma: are dopamine agonists still first choice?
dc.typeJournal article
dc.type.descriptionC3 - Articles (Letter/ Note)
dc.type.codeC - Journal Articles
gro.facultyGriffith Health, School of Medicine
gro.date.issued2011
gro.hasfulltextNo Full Text
gro.griffith.authorBeran, Roy G.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record